American Research Journal of Biomedical Engineering       cover
Open Access

American Research Journal of Biomedical Engineering

ISSN (Online):

DOI: 10.46568/arjbme

Research Article Vol. 2, Issue 1 2024 Open Access

The Co-Evaluation of Ovarian Epithelium Karyorrhexis and Oophoritis after the Erythropoietin Effect on Ovarian Ischemia Reperfusion Injury

Constantinos Tsompos1*, Constantinos Panoulis2, Konstantinos Toutouzas3 Aggeliki Triantafyllou4, George C. Zografos5, Kalliopi Tsarea6, Maria Karamperi7 Apostolos Papalois8

Abstract

Aim: This study co-evaluated the 2 quoted histologic variables after the erythropoietin (Epo) administration. The calculation was based on the results of 2 preliminary studies, each one evaluating a respective histologic variable of ovarian epithelium karyorrhexis (OK) or oophoritis (OI) in an induced ischemia reperfusion animal experiment. Materials and Methods: The 2 main experimental endpoints at which the OK and OI scores were evaluated was the 60th reperfusion min(for the groups A and C) and the 120th reperfusion min (for the groups B and D). Specially, the groups A and B were processed without drugs, whereas the groups C and D after Epo administration. Results: The first preliminary study showed that Eponon significantly recessed the ovarian epithelium karyorrhexis (OK) within the “without lesions alterations” grade by 0.0818182 [-0.2159977 - 0.0523614] (p-value=0.2246)1. However, the second preliminary study showed that Epo significantly enhanced oophoritis (OI) within the “without lesions alterations” grade by 0.1363636 [0.0421443 - 0.230583] (p-value=0.0057)2. These 2 studies were co-evaluated since they came from the same experimental setting. This study investigated the combined diagnostic value of both variables together. Conclusions: Epo has a hardly deteriorating potency of these histologic parameters within the “without lesions alterations” grade by 0.0272727 [-0.0556778 - +0.1102233] (p-value=0.5097) since they were co-evaluated together.